Skip to content
Clinical Trial Events
SITC 2026 41st Annual Meeting

Talk General Sessions track

Session 303: COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender?

Sun, Nov 8, 2026 · 10:45 AM–12:25 PM MST Phoenix Convention Center

About this session

General session on bispecific VEGF/PD(L)-1 inhibitors.